A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen
- Sensitivity and Specificity
− COVID-19 - Sensitivity 93.9%, Specificity 100%
− Flu A - Sensitivity 91.4%, Specificity 95.7%
− Flu B - Sensitivity 87.6%, Specificity 95.9% - FDA Emergency Use Authorization (EUA)
- Visually read in 15 minutes
- Flocked nasopharyngeal swab for superior specimen collection and patient comfort
CPT CODES
- COVID-19: 87811QW
- FLU A: 87804QW
- FLU B: 87804QW-59
